Sanofi leads pharma industry deeper into sustainability-linked finance
Sanofi, the French pharmaceutical company, has signed €8bn of syndicated loans, claiming to be the first large biopharma group to switch its syndicated bank lines to sustainability-linked metrics.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: